EUCTR2009-010917-61-SE进行中（未招募）不适用
Glucocorticoid Replacement in Addison's disease
Haukeland University hospital0 个研究点目标入组 40 人开始时间: 2010年7月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with verified primary adrenal insufficiency (Addison’s disease) will be included. In case of concomitant endocrine/autoimmune diseases these should be on stable treatment during the study period. The patient will have to give written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with diabetes mellitus on insulin treatment will not be included in this study. Other exclusion criteria are cardiovascular disease, malignant disease and pregnancy, and pharmacological treatment with glucocorticoids or drugs that interfere with cortisol metabolism (antiepileptics, rifampicin, St Johns wart). The patients should not take grapefruit juice the last two weeks before or during the study period.
研究者
相似试验
已完成
2 期
Glucocorticoid Treatment in Addison's DiseaseAddison's DiseaseNCT01063569Haukeland University Hospital33
终止
2 期
Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 DiabetesAddison DiseaseType 1 DiabetesNCT01840189Haukeland University Hospital4
进行中（未招募）
不适用
Optimal glucocorticoid replacement therapy in adrenocorticotropin (ACTH) deficient hypopituitary patients - Optimal glucocorticoid replacement10 male patients with hypopituitarism resulting in ACTH (adrenocorticotropin) deficiency (ICD E23.0) will be studied on varying doses of hydrocortisone replacement therapy. THis is not a new medication for these patients.10 healthy male volunteers will be studied as control subjects. They will NOT receive hydrocortisone.MedDRA version: 9.1Level: LLTClassification code 10021067Term: HypopituitarismMedDRA version: 9.1Level: LLTClassification code 10033662Term: PanhypopituitarismMedDRA version: 9.1Level: LLTClassification code 10057217Term: Isolated ACTH deficiencyEUCTR2007-005018-37-IEAmar Agha20
已完成
不适用
Antiglucocorticoid augmentation of antiDepressants in Depression: the ADD studyMajor depressionMental and Behavioural DisordersDepressionISRCTN45338259orthumberland, Tyne and Wear NHS Foundation Trust (UK)190
进行中（未招募）
1 期
Study to determine whether the addition of Metyrapone increases effects of anti-depressants in patients with depression.depressionEUCTR2009-015165-31-GBorthumberland, Tyne and Wear NHS Foundation Trust190